ArticleCancer medicine2023

Should we abandon hormonal therapy in endometrial cancer? Outcomes of recurrent and metastatic endometrial cancer treated with systemic progestins.

A Kulkarni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.